$HUTCHMED(00013)$ has been consistently profitable since two years ago, truly embodying the principle of "steady progress over the long term."
The purpose of any company is to create value for its shareholders, and HUTCHMED has gained market trust through its stable profitability and long-term development plans. Over its 19 years since listing, the management has adhered to prudent business practices, with strong free cash flow and resilience to risks.
As an innovative pharmaceutical company that fits the value investment model, HUTCHMED holds great potential for the future. I have full confidence in this stock, will continue to hold firmly, and look forward to the future profitability!
Comments